Clinical studies on penetration of biapenem to postoperative peritoneal exudate

K. Ishibiki; Y. Saikawa; S. Shibata

Clinical studies on penetration of biapenem to postoperative peritoneal exudate

K. Ishibiki, Y. Saikawa, S. Shibata

Research output: Contribution to journal › Article › peer-review

Abstract

We studied biapenem (BIPM), a new carbapenem antibiotic, in terms of postoperative penetration into peritoneal exudate. We measured daily concentration of BIPM in peritoneal exudate after radical gastrectomy for gastric cancer or gastric leiomyosarcoma for 3 days. BIPM was administered by intravenous drip infusion at a dose of 0.3 g twice a day. The average concentrations in peritoneal exudate in 3 patients were 0.68, 0.33 and 0.11 μg/ml on days 1, 2 and 3, respectively. No side effects and no abnormal laboratory findings were observed.

Original language	English
Pages (from-to)	683-685
Number of pages	3
Journal	Chemotherapy
Volume	42
Issue number	SUPPL. 4
Publication status	Published - 1994

ASJC Scopus subject areas

Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{9f95d1fea62844babb05607ccb885f28,

title = "Clinical studies on penetration of biapenem to postoperative peritoneal exudate",

abstract = "We studied biapenem (BIPM), a new carbapenem antibiotic, in terms of postoperative penetration into peritoneal exudate. We measured daily concentration of BIPM in peritoneal exudate after radical gastrectomy for gastric cancer or gastric leiomyosarcoma for 3 days. BIPM was administered by intravenous drip infusion at a dose of 0.3 g twice a day. The average concentrations in peritoneal exudate in 3 patients were 0.68, 0.33 and 0.11 μg/ml on days 1, 2 and 3, respectively. No side effects and no abnormal laboratory findings were observed.",

author = "K. Ishibiki and Y. Saikawa and S. Shibata",

year = "1994",

language = "English",

volume = "42",

pages = "683--685",

journal = "Chemotherapy",

issn = "0009-3165",

publisher = "S. Karger AG",

number = "SUPPL. 4",

}

TY - JOUR

T1 - Clinical studies on penetration of biapenem to postoperative peritoneal exudate

AU - Ishibiki, K.

AU - Saikawa, Y.

AU - Shibata, S.

PY - 1994

Y1 - 1994

N2 - We studied biapenem (BIPM), a new carbapenem antibiotic, in terms of postoperative penetration into peritoneal exudate. We measured daily concentration of BIPM in peritoneal exudate after radical gastrectomy for gastric cancer or gastric leiomyosarcoma for 3 days. BIPM was administered by intravenous drip infusion at a dose of 0.3 g twice a day. The average concentrations in peritoneal exudate in 3 patients were 0.68, 0.33 and 0.11 μg/ml on days 1, 2 and 3, respectively. No side effects and no abnormal laboratory findings were observed.

AB - We studied biapenem (BIPM), a new carbapenem antibiotic, in terms of postoperative penetration into peritoneal exudate. We measured daily concentration of BIPM in peritoneal exudate after radical gastrectomy for gastric cancer or gastric leiomyosarcoma for 3 days. BIPM was administered by intravenous drip infusion at a dose of 0.3 g twice a day. The average concentrations in peritoneal exudate in 3 patients were 0.68, 0.33 and 0.11 μg/ml on days 1, 2 and 3, respectively. No side effects and no abnormal laboratory findings were observed.

UR - http://www.scopus.com/inward/record.url?scp=0028576810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028576810&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028576810

VL - 42

SP - 683

EP - 685

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3165

IS - SUPPL. 4

ER -

Clinical studies on penetration of biapenem to postoperative peritoneal exudate

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this